The Food and Drug Administration Friday issued recommendations for health care providers to reduce the risk of adverse events associated with surgical staplers and staples for internal use. Among other recommendations, FDA recommends providers carefully follow the stapler manufacturer’s instructions for use, have a range of staple sizes available and select the appropriate size cartridge for the tissue. Since 2011, the agency has received more than 41,000 medical device reports for surgical staplers and staples for internal use, including 366 deaths. FDA plans this year to issue draft guidance to manufacturers on information to include in their product labeling and to hold a public meeting on whether to reclassify the staplers as Class II devices, which would allow the agency to establish mandatory special controls to mitigate known risks.

Related News Articles

Headline
Yale New Haven Health will receive the 2021 AHA Quest for Quality Prize this week at AHA’s annual Leadership Summit for its deep commitment to improving the…
News
Reps. Peter Welch, D-Vt., Suzan DelBene, D-Wash., Darin LaHood, R-Ill., and Brad Wenstrup, R-Ohio, yesterday reintroduced the Value in Health Care Act, AHA-…
News
The Centers for Medicare & Medicaid Services today advised clinicians in the Medicare Quality Payment Program who earned but did not receive an alternative…
Headline
The AHA and American Medical Association last week urged the Centers for Medicare & Medicaid Services to delay until at least Jan. 1, 2023, the deadline…
News
Medical Action Industries Inc. has recalled more than 8,000 medical convenience kits due to fungal contamination risk from an applicator used to sanitize skin…
Blog
A recent report from the Lown Institute that ranks hospitals on what they deem to be unnecessary hospital services, tests and procedures attempts to make…